← Back to Search

MedViewer report for Medication Adherence (ENLIGHTEN Trial)

N/A
Waitlist Available
Led By Angela Kashuba, PharmD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time 1 to time 2 prior to or on visit 1 (day 1)
Awards & highlights

ENLIGHTEN Trial Summary

This trial is to see if the Medviewer, which uses infrared technology to analyze patient hair samples, can provide information on antiretroviral medication adherence in real-time.

ENLIGHTEN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time 1 to time 2 prior to or on visit 1 (day 1)
This trial's timeline: 3 weeks for screening, Varies for treatment, and time 1 to time 2 prior to or on visit 1 (day 1) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of Contacted Patients That Were Eligible for a Screening Visit and Agreed to Participate in the Study
Percent of Patient Participants That Received a MedViewer Report as Planned
Anti-Retroviral Agents
+1 more
Secondary outcome measures
Among Patient Participants That Did Dot Receive a MedViewer Report, Percent of Patient Participants That Did Not Receive the MedViewer for a Given Reason or Reasons
Mean Hours From Patient Participant Hair Sample Processing Initiation to MedViewer Report Delivery to Designated Research Staff Member
Mean Usefulness Score for the MedViewer Report to Promote ART (Antiretroviral) Adherence
+4 more

ENLIGHTEN Trial Design

2Treatment groups
Experimental Treatment
Group I: Provider participantsExperimental Treatment1 Intervention
Patient and provider will view and discuss results of the MedViewer test.
Group II: Patient participantsExperimental Treatment1 Intervention
Patient and provider will view and discuss results of the MedViewer test.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MedViewer report
2020
N/A
~60

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,190,985 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,269 Previous Clinical Trials
5,481,430 Total Patients Enrolled
Angela Kashuba, PharmDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
3 Previous Clinical Trials
31 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence (ENLIGHTEN)
2020. "Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence (ENLIGHTEN)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04232540.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top